


Healthcare News Roundup: Personne
HSMN NewsFeed - 10 Jan 2019
Astellas Announces Key Senior Leadership Promotions and New Hire in Medical and Development Organization
Astellas Announces Key Senior Leadership Promotions and New Hire in Medical and Development Organization
HSMN NewsFeed - 10 Jan 2019
GigaGen Announces Appointment of Erica Stone, Ph.D., as Director, Immuno-Oncology
GigaGen Announces Appointment of Erica Stone, Ph.D., as Director, Immuno-Oncology
HSMN NewsFeed - 4 Jan 2019
LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr Pharmaceutical
LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr Pharmaceutical
HSMN NewsFeed - 4 Jan 2019
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
HSMN NewsFeed - 2 Jan 2019
LIGHTMED Corporation Founder and Executive Chairman Gary Lee Reassumes CEO Role
LIGHTMED Corporation Founder and Executive Chairman Gary Lee Reassumes CEO Role
HSMN NewsFeed - 2 Jan 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
HSMN NewsFeed - 13 Dec 2018
Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer
Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer
HSMN NewsFeed - 12 Dec 2018
Astellas Promotes Lei Ding to vice president, Payer Strategy, Contracts, and Pricing
Astellas Promotes Lei Ding to vice president, Payer Strategy, Contracts, and Pricing
HSMN NewsFeed - 6 Dec 2018
Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors
Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors
HSMN NewsFeed - 3 Dec 2018
Variant Pharmaceuticals Secures $10 Million in Financing from Korean Company, Incon Co., Ltd.
Variant Pharmaceuticals Secures $10 Million in Financing from Korean Company, Incon Co., Ltd.
HSMN NewsFeed - 26 Nov 2018
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
